A recent meta-analysis showed that cfDNA is more valuable for diagnosing HCC than AFP [15], but the use of cfDNA alone is not recommended for HCC diagnosis due to its non-robust performance. This evidence concerns the gene AFP and hepatocellular carcinoma.